Treatment for Low Free Testosterone and Total Testosterone Levels

Diagnostic Confirmation

The diagnosis of testosterone deficiency requires both consistently low testosterone measurements (<300 ng/dL) on at least two separate morning tests AND the presence of symptoms/signs, according to The Journal of Urology 1, 2
Free testosterone measurement is essential when evaluating low total testosterone in patients with obesity or suspected binding protein abnormalities, as stated by Gastroenterology 3
Clinical symptoms that warrant evaluation include reduced energy, reduced endurance, fatigue, depression, reduced motivation, poor concentration, infertility, reduced sex drive, and changes in erectile function, as reported by The Journal of Urology 1, 2

Transdermal testosterone preparations (gels, patches) are generally preferred as first-line options due to their steady-state pharmacokinetics, according to Praxis Medical Insights 4

After initiating treatment, monitor testosterone levels at 2-3 months and after any dose change, as recommended by Praxis Medical Insights 4
For patients receiving testosterone injections, levels should be measured midway between injections, according to Praxis Medical Insights 4
Once stable levels are confirmed, monitoring every 6-12 months is typically sufficient, as stated by Praxis Medical Insights 4
Target normal free testosterone levels rather than just total testosterone, especially in patients with abnormal SHBG levels, as recommended by Praxis Medical Insights 4

Before initiating treatment, measure luteinizing hormone (LH) levels to determine if hypogonadism is primary or secondary, as suggested by Praxis Medical Insights 4
Consider measuring serum prolactin to rule out hyperprolactinemia as a cause of secondary hypogonadism, according to Praxis Medical Insights 4
In patients with obesity, low total testosterone may be due to low sex hormone-binding globulin, requiring free testosterone measurement to confirm true testosterone deficiency, as reported by Gastroenterology 3
Increased aromatization of testosterone to estradiol in adipose tissue can lead to estradiol-mediated negative feedback suppressing pituitary LH secretion in obese men, as stated by Gastroenterology 3

Relying solely on total testosterone without measuring free testosterone in patients with suspected binding protein abnormalities, as warned by Gastroenterology 3
Initiating treatment based on a single testosterone measurement rather than confirming with two separate morning tests, as cautioned by The Journal of Urology 1, 2
Treating patients with testosterone without confirming the presence of both low testosterone levels and clinical symptoms, as advised against by The Journal of Urology 1, 2
Failing to monitor testosterone levels after initiating therapy - nearly half of men on testosterone therapy do not have their levels checked after starting treatment, as reported by The Journal of Urology 2